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Abstract
Adenosine to Inosine (A-to-I) RNA editing is a site-specific modification of RNA transcripts, catalyzed by members of the
ADAR (Adenosine Deaminase Acting on RNA) protein family. RNA editing occurs in human RNA in thousands of different
sites. Some of the sites are located in protein-coding regions but the majority is found in non-coding regions, such as
39UTRs, 59UTRs and introns - mainly in Alu elements. While editing is found in all tissues, the highest levels of editing are
found in the brain. It was shown that editing levels within protein-coding regions are increased during embryogenesis and
after birth and that RNA editing is crucial for organism viability as well as for normal development. In this study we
characterized the A-to-I RNA editing phenomenon during neuronal and spontaneous differentiation of human embryonic
stem cells (hESCs). We identified high editing levels of Alu repetitive elements in hESCs and demonstrated a global decrease
in editing levels of non-coding Alu sites when hESCs are differentiating, particularly into the neural lineage. Using RNA
interference, we showed that the elevated editing levels of Alu elements in undifferentiated hESCs are highly dependent on
ADAR1. DNA microarray analysis showed that ADAR1 knockdown has a global effect on gene expression in hESCs and leads
to a significant increase in RNA expression levels of genes involved in differentiation and development processes, including
neurogenesis. Taken together, we speculate that A-to-I editing of Alu sequences plays a role in the regulation of hESC early
differentiation decisions.
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Introduction
Human embryonic stem cells (hESCs) are derived from the inner
cell mass of blastocysts [1,2] Their ability to grow for long periods,
while preserving normal karyotype and pluripotency holds enormous
potential for these cells to become important tools in cell
differentiation and early developmental research, drug discovery
and for future regenerative medicine. The pluripotency of these cells
can be easily demonstrated when they are grown in suspension where
they spontaneously differentiate and form aggregates named
Embryoid Bodies (EBs) in modes which recapitulate early events of
embryonic development [3,4]. It has been shown that mature EBs
include many types of cells which represent derivatives of the three
embryonic germ layers [3,4]. In addition, it was shown that by
manipulating their growth conditions in specific ways, ESCs
differentiation can be directed toward specific lineages by similar
mechanisms to those occurring in vivo [5].
The transcriptomeand the proteomediversity have been shown to
be regulated by post-transcriptional RNA processing mechanisms;
the best studied being alternative splicing [6]. RNA editing is another
post transcriptional processing mechanism. It generates RNA
sequences that are different from the ones encoded by the genome,
and thereby contributes to the diversity of gene products [7,8]. It was
shown by our group as well as by other researchers that RNA editing
is a global phenomenon, affecting thousands ofgenes [9,10,11,12,13].
RNA editing increases significantly the complexity of transcription
products and has a major influence on cellphysiology [7,8]. The most
common editing type is the conversion of Adenosine to Inosine (A–to-
I) by hydrolytic deamination in double strand RNA regions
[7,9,10,11,12]. A–to–I RNA editing is processed by enzymes that
belong to the ADAR (Adenosine Deaminase Acting on RNA) protein
family and are encoded by the ADAR1, ADAR2 and ADAR3 genes
[7]. ADAR1 and ADAR2 are expressed ubiquitously and have an
active deaminase domain. In contrast, ADAR3 is expressed only in
the brain and its activity as an editing enzyme remains to be
demonstrated [7]. ADAR1 has two protein isoforms. ADAR1 p110 is
located exclusively in the nucleus and its RNA is transcribed from the
constitutive promoters 1B and 1C. In contrast, ADAR1 p150 is
located both in the cytoplasm and in the nucleus and its RNA is
transcribed from the interferon induced 1A promoter [14]. In pre-
messenger RNAs, the editing sites can be found in protein-coding
sequences [7,13,15,16,17] or in non-coding sequences such as UTRs
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recognizes Inosine as Guanosine, editing in coding sequences can
recode an amino acid and therefore affect the protein structure and
function [7,13,15,16,17]. Most editing sites are found in non-coding
sequences; about 90% of them are located within Alu repetitive
elements [7,9,10,11,12]. The presence of Inosines in non-coding
sequences may influence multiple cellular processes such as RNA
interference, microRNA biogenesis and function, RNA stability,
RNA localization, chromatin structure and alternative splicing
[18,19,20,21,22,23]. The editing level in the brain is particularly
high [24]. Several findings suggestan important rolefor RNA editing
in the central nervous system [7,15,17]. Abnormal editing patterns
were shown in CNS disorders including epilepsy, amyotrophic lateral
sclerosis (ALS), brain ischemia, depression and brain tumors
[7,25,26,27,28]. Abnormal behavior was demonstrated in C. elegans
and D.melanogaster when the ADAR enzymes were knocked-out
[29,30].
Previous studies showed that there is a significant increase in
editing levels of protein-coding regions during brain development
and in-vitro neural differentiation [31,32,33]. It was shown that in
mice, ADAR1 is crucial for embryonic development and that
ADAR2 is vital for normal brain function [34,35,36,37].
We show here that A-to-I RNA editing of Alu elements is high in
hESCs and decreases during differentiation. In addition, we show
that ADAR1 has a global effect on gene expression in hESCs and
suggest a role for ADAR1 mediated-editing of Alu elements in the
regulation of hESC differentiation.
Results
Low editing levels in protein-coding regions during
spontaneous and neuronal differentiation of hESCs
Editing sites within protein-coding regions are relatively rare.
Yet this type of RNA editing was shown to have a large effect on
protein function and cell physiology [7,15,17]. In addition, editing
within protein-coding regions was shown to be highly regulated
during development and cell differentiation [31,32,33]. The
editing levels in protein-coding regions of hESCs clonal line
H9.2 were monitored during spontaneous differentiation or during
neuronal differentiation (Figure 1 and Figure S1). RNA editing
levels were measured by direct sequencing or SEQUENOM
MassArray analysis. Editing was monitored in the coding region of
five genes; GluR2 (Site Q/R), BLCAP (Site Y/C), 5HT2CR (Sites
A-E), FLNA (Site Q/R) and CYFIP2 (Site K/E) (Figure 1 and
references [15,16,17]). Significant editing levels were detected in
GluR2, BLCAP and 5HT2CR (Sites A, C and D). GluR2 was
almost 100% edited both before and after hESCs spontaneous or
neuronal differentiation similar to the findings in adult brain. A
modest decrease at the editing level of BLCAP was observed
during neuronal differentiation (29.2%–23.6%). We observed a
significant decrease in the editing level of 5HT2CR (Site A) during
both neuronal differentiation and spontaneous differentiation
(41.5%–8.8% and 41.5%–18.3%, respectively). In contrast, we
observed a significant increase in the editing level of 5HT2CR
(Site B) during the neuronal differentiation (5%–19.4%) and also
of 5HT2CR (Site D), particularly, during the spontaneous
differentiation (0%–15.2%). FLNA and CYFIP2 that are signifi-
cantly edited in the adult [17,38] were only marginally edited in
undifferentiated, neuronal and EB cultures. Similarly, editing
levels of 5HT2CR sites were much lower in hESCs and their
derivatives compared to those observed in adult human brain [17].
Similar levels of editing were observed in the hESCs line I6
(data not shown). The low editing observed is in agreement with
previous studies that showed increased editing levels within
protein-coding regions during development [31,32,33]. In addi-
tion, the results show that there is no consistent pattern of editing
regulation among protein-coding regions during hESCs neuronal
and spontaneous differentiation.
RNA editing levels within Alu sequences decrease during
neuronal and spontaneous differentiations of hESCs
The presence of Inosines in non-coding sequences may
influence multiple cellular processes related to RNA interference
and microRNA biogenesis and function, RNA stability, RNA
localization, chromatin structure and alternative splicing
[18,19,20,21,22,23]. Since, these processes are highly regulated
during ESCs differentiation [39,40,41] it was of interest to monitor
the levels of editing within non-coding RNA regions during hESCs
differentiation (Figure S1).
The vast majority of A-to-I RNA editing events was found in
non-coding Alu elements [7,9,10,11,12]. We monitored the editing
levels of eight Alu sequences which have been shown to be edited
in adult tissues. These Alu elements are embedded in 39UTRs or
introns of the following transcripts: C4orf29/hypothetical protein
FLJ21106, F11R, FANCC, BRCA1, MDM4, RBBP9, CARD11
and THRAP1/MED13 ([9,26] and data not shown). In order to
monitor differences in the editing levels of differentiated and
undifferentiated hESCs, we used the SEQUENOME MassArray
technology or direct sequencing.
All the Alu elements in the above transcripts were found to be
edited except for THRAP1 (Figure 2A). The Alu sequences within
FANCC, BRCA1, C4orf29 and F11R transcripts were edited at
levels above 28% (Figure 2A). These findings indicate that Alu
sequences are highly edited in both adult tissues as well as in
hESCs. There was a significant decrease, from 20.7% to 12.4%, in
the average editing level of Alu sequences as a result of neuronal
differentiation (n=7 edited Alu regions, p,0.016 according to
Wilcoxon signed-rank test; Figure 2A). We observed also a
significant decrease, from 20.7% to 15.4%, in the average editing
level of Alu sequences in the spontaneous differentiation (n=7
edited Alu regions, p,0.016 according to Wilcoxon signed-rank
test; Figure 2A). Of note, the decrease in editing levels was
consistent among different Alu sequences during neuronal
differentiation (Figure 2A). In most Alu sequences the decrease in
the editing level was less prominent during the spontaneous
differentiation versus the neuronal differentiation (Figure 2A, B,
C). In order to map and quantify all the clustered editing sites
found in two representative genes, C4orf29 and F11R, they were
monitored by direct sequencing. The analysis shows that during
neuronal differentiation, the editing levels of the clustered sites
were consistently decreased (Figure 2B, C). Taken together, these
results suggest that decrease in Alu editing levels during neuronal
differentiation is a global phenomenon. A similar trend was
observed also during early spontaneous differentiation (After
differentiation of 1–2 weeks) (Figure S2). A detailed analysis of
the editing levels in C4orf29 and F11R during 3 weeks of
spontaneous differentiation is shown in Figure S2.
ADAR expression levels increase during neuronal and
spontaneous differentiation of hESCs
The alterations in editing levels we observed may be a result of
differences in the expression of ADAR1-3 levels. In order to
monitor changes in ADARs during differentiation, we compared
the mRNA level of ADAR1-3 between H9.2 hESCs and their
neuronal and EBs derivatives by qRT-PCR (Figure 3A and Figure
S1). We detected three to five fold upregulation in mRNA
expression levels of ADAR2 and ADAR3 as a result of
A-to-I RNA Editing in hESCs
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levels of the ADAR1 p110 isoform was observed during neuronal
differentiation but not during spontaneous differentiation. The
mRNA level of the ADAR1 p150 isoform did not change
significantly in both types of differentiation. In agreement with
the fact that ADAR3 is brain specific in the adult and that ADAR1
p110 mRNA isoform is expressed at a relatively high level in the
brain [7,42], their expression levels in the neuronal culture were
higher compared to EBs culture (2.17 and 1.55 folds, respectively;
Figure 3A). In contrast, ADAR2 expression was similar in the
neuronal and EBs cultures (Figure 3A).
Protein levels of the two ADAR1 isoforms were similar in
hESCs, neuronal and EBs cultures (Figure 3B). In agreement with
qRT-PCR data, ADAR2 protein expression levels in differentiated
cultures were significantly higher compared to undifferentiated
hESCs, without a significant difference between neuronal and EBs
cultures (Figure 3B). The qRT-PCR data together with DNA
microarray analyses indicate that the ADAR1 mRNA levels are
significantly higher than those of ADAR2 and ADAR3 in
undifferentiated hESCs (Figure S3).
The relative mRNA levels of ADAR1 and ADAR2 were also
measured during spontaneous differentiation of the hESCs line I6
and compared with those of adult human cortex which is
characterized by high editing levels (Figure S4). The regulation
of ADAR mRNA expression level during differentiation was found
to be largely similar in the two hESCs lines (H9.2 and I6)
(Figure 3A and Figure S4). In addition, ADAR1 expression was
only moderately lower in hESCs versus the cortex while ADAR2
expression was significantly lower (Figure S4). These results
suggest that ADAR1 plays a significant role in hESCs at early
stages of differentiation while ADAR2 and ADAR3 may be
important at later stages.
RNA editing levels of Alu sequences are highly
dependent on ADAR1 in hESCs
Alu sequences are members of the large SINEs (Short
Interspersed Elements) family of repetitive elements which is
found in all mammals. Recently, it was shown that ADAR1 is
involved significantly in editing of SINE elements in mice [43]. In
addition, we found that the ADAR1 mRNA level is significantly
higher than that of ADAR2 and ADAR3 in hESCs (Figure S3).
Therefore, we hypothesized that in hESCs ADAR1 has a
substantial effect on RNA editing of Alu elements. To test this
hypothesis, we specifically silenced ADAR1 expression by RNA
interference. Undifferentiated cultures of hESCs were transfected
with ADAR1 specific siRNA or with non-target siRNA as negative
control and were subjected to qRT-PCR analysis. 44 h after
transfection, the mRNA levels of the two ADAR1 isoforms, p110
and p150, decreased by 66% and 75% respectively, in cells treated
by ADAR1-siRNA (Figure 4A). The silencing effect of p110 and
p150 was decreased to 33% and 50%, respectively, 72 h after
siRNA transfection (Figure 4A). The results were supported by
western blotting. According to the western blot analysis, the
ADAR1-p110 isoform was down-regulated 44 h after transfection.
In contrast, no significant difference was observed after 72 h
(Figure 4B). According to densitometry analysis normalized to beta
actin, the ratios of p110 levels between knockdown and control
were: 1:5.53 after 44 h and 1.13:1 after 72 h, respectively.
ADAR1-p150 was also down-regulated 44 h after transfection
(Figure 4B). The accurate quantification of ADAR1-p150 is not
provided due to the very low expression level of this isoform.
In order to study the effect of decreased ADAR1 levels on the
editing levels we used direct sequencing or the SEQUENOME
MassArray technology for the quantification of editing. As
expected, 44 h after transfection the editing level of BLCAP(Y/
C) which is a specific target of ADAR1 [43] was 14.3% versus
23.5% in the control (Figure 4C). Both 44 h and 72 h after
siRNAs transfection, ADAR1 knockdown cells had ,two fold
decrease in the average editing level of Alu elements (n=6 Alu
elements, p,0.04 according to Wilcoxon signed-rank test)
(Figure 4C). It is important to note that the editing levels, 72 h
after the ADAR1-siRNA transfection, remained low in spite of the
fact that ADAR1 protein expression levels were increased and
became the same as in the control. A possible explanation for this
discrepancy can be that ADAR1 activity doesn’t appear
immediately after its translation because of unknown secondary
processes which are required to mediate its editing function.
Therefore, a large proportion of the RNAs remained unedited.
Figure 1. RNA editing within protein- coding regions during spontaneous and neuronal differentiation of hESCs. H9.2 hESCs were
differentiated spontaneously or to highly enriched neuronal culture by EBs derivation or by using all-trans retinoic acid, respectively. The editing
levels of BLCAP, CYFIP2, and FLNA mRNAs at sites: Y/C, K/E and Q/R, respectively, were measured by the SEQUENOME MassArray technology. The
editing levels of 5HT2CR mRNA at sites: A, B, C, D and E and the editing level of GluR2 at site Q/R were measured by direct sequencing. Absence of
bars means that editing is under the detection level.
doi:10.1371/journal.pone.0011173.g001
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observed in two independent experiments, although ADAR1
expression level recovered after 72 hours and became equal to that
of the control cells. To evaluate the knockdown effect on clustered
editing sites within Alu sequences, the editing levels in F11R and
C4orf29 were quantified by direct sequencing. This analysis
showed that, both 44 h and 72 h after siRNA transfection, the
ADAR1 silencing caused a global decrease in editing in the
clustered editing sites within these Alu sequences (Figure 4D, E).
Taken together, these data show that the editing levels of Alu
sequences in hESCs are significantly dependent on ADAR1.
Global effect of ADAR1 silencing on gene expression in
hESCs
RNA editing is a major post transcriptional modification that
affects global gene expression and tends to occur at high levels in
hESCs. We therefore speculated that it has a significant effect on
the regulation of hESC differentiation. The finding that significant
regulation of Alu editing occurs during hESC differentiation
further supports that assumption. Therefore, we predicted that
ADAR1 knockdown will have a significant effect on hESC global
gene expression and phenotype. To study the effect of ADAR1
knockdown on gene expression, we performed microarray analysis
using RNA extracted from the ADAR1 knockdown and the non-
target control siRNA treated hESCs, 44 h after transfection. The
expression levels of 867 annotated genes changed as a result of
ADAR1 knockdown by at least 1.5 fold. Among them, 390 genes
were upregulated and 477 genes were downregulated. The genes
were clustered into functional groups by the DAVID Gene
Functional Classification Tool (Table S1 and Table S2). Of
particular interest were gene categories which are related to cell
differentiation processes in general and to neurogenesis in
particular. We found that both groups are significantly overrep-
resented among the upregulated, but not among the downregu-
lated genes (p,0.0001 and p.0.8, respectively; Figure 5, Table 1,
Table S1 and Table S2). Interestingly, that trend is also evident for
most other functional groups of genes which are related to cell
differentiation/development processes (Tables S1 and S2). Among
the downregulated genes, those related to nucleic acid metabolism
and protein processing were significantly overrepresented
(Figure 5, Table 1, Table S1 and Table S2). In addition, according
to Ingenuity IPA software, among the functional groups the cancer
Figure 2. RNA editing levels within Alu sequences decrease during neuronal and spontaneous differentiation of hESCs. The editing
levels within Alu sequences of eight genes during the differentiation of H9.2 hESCs were measured. (A) RNA editing levels of C4orf29, F11R and
THRAP1 Alu sequences were measured by direct sequencing. C4orf29 editing levels represent the average of 10 sites and F11R editing levels
represent the average of 11 sites. Editing levels within Alu sequences of: RBBP9, FANCC, MDM4, BRCA1 and CARD11 were measured by the
SEQUENOME MassArray technology in specific discrete sites. No editing was detected in the Alu of THRAP1 (B, C) A detailed representation of editing
levels of the Alu elements of C4orf29 and F11R in the undifferentiated hESCs, the neuronal culture and the EBs. Specific localization of each editing
site is given in table S7.
doi:10.1371/journal.pone.0011173.g002
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was affected by ADAR1 knockdown. Both upregulated and
downregulated cancer related genes were significantly overrepre-
sented (p,0.05; Figure 5, Table 1 and Table S3).
Differentiation of ESCs into cells of the three germ layers is
characterized by a decrease at the mRNA level of genes such as
two of the pluripotency master regulators Oct4 and Nanog and in
significant changes of their specific morphology [2,44,45,46]. We
didn’t observe differences at the mRNA level of Oct4 and Nanog.
(Figure S5A). In addition, cells after siRNA transfection with either
ADAR1 specific or non-target control siRNA (44 h and 72 h)
didn’t exhibit significant morphological changes (Figure S5B).
Taken together, we conclude that ADAR1 is not essential for
maintenance of hESCs undifferentiated state, at least not in the
short term.
Although ADAR1 silencing didn’t affect hESCs status under
our experimental conditions (cells were grown under culture
conditions which are designed to inhibit cell differentiation), the
expression level of genes related to differentiation/developmental
processes increased. Therefore, we suggest that differentiation of
ADAR1 knockdown cells may be accelerated under conditions
which support differentiation.
Discussion
Previous findings on RNA editing in the context of mammalian
development are based on animal models or on the analysis of
human tissues at different stages of development. These studies
showed that RNA editing levels in protein-coding regions increase
significantly during brain development [31,32] and that the
ADAR enzymes are important for normal development
[34,35,36,37]. However, the relevance of animal models to the
role of RNA editing in human development is limited since it was
shown by our previous work that RNA editing level in humans is
much higher than that of laboratory animals [38]. In addition, the
reported studies of editing in human tissues analyzed only samples
taken after mid-gestation when most of the differentiation
processes had already been completed. Furthermore, previous
studies regarding RNA editing in development analyzed only
editing sites within protein-coding regions and did not address the
vast majority of editing events which occur within non-coding
regions. Therefore, the relevance of these studies to cell
differentiation research is limited. In the current study, we
characterized RNA editing in both coding and non-coding RNA
sequences in hESCs and their differentiated progenies, which
provide a good model for research of early cell differentiation
processes. As there is a significant increase in editing within
protein-coding sequences during development, it was expected
that RNA editing levels are low in human blastocysts and therefore
also in its hESC derivatives. In addition, it was predicted that
differentiation of hESCs, particular to the neural lineage, will be
accompanied by increased RNA editing. Interestingly enough,
these predictions were contradicted by our results: We found
significant editing levels of Alu sequences in undifferentiated
hESCs and observed that differentiation, particularly to the neural
lineage, was accompanied by decreased editing levels. In addition,
no consistent pattern of editing regulation among protein-coding
regions was observed. Therefore, it can be suggested that the
widespread RNA editing in non-coding regions has a significant
role in hESC early differentiation. The high levels of editing of
non-coding sequences in hESCs and the decrease in global editing
during differentiation suggest that the presence of Inosines in
hESC transcripts may have significant effects on cellular
regulatory mechanisms such as microRNA biogenesis and
function, regulation of mRNA localization and stability, chromatin
structure and alternative splicing which are known to be highly
regulated during hESC differentiation [39,40,41].
mRNAs containing hyperedited inverted repetitive elements in
their 3’ untranslated regions (3’UTRs) are retained in nuclear
paraspeckle-associated complexes containing the proteins p54
nrb,
PSF, and PSP1alpha [21,47]. Chen et al reported recently that
39UTR edited sequences in hESCs escape nuclear retention [47].
They showed that paraspeckles are absent from hESCs and only
appear upon differentiation. In addition they showed that
Figure 3. ADAR expression levels increase during neuronal and spontaneous differentiation of hESCs. (A) The relative expression levels
of ADAR mRNAs during H9.2 hESCs differentiations. The analysis was performed by qRT-PCR. Normalization was performed by GAPDH. (B) Western
blot analysis of ADAR proteins expression levels during H9.2 hESCs differentiations. lane1: Undifferentiated hESCs, lane2: Neuronal culture, lane3: EBs,
lane4: MEFs. ACTB -beta Actin.
doi:10.1371/journal.pone.0011173.g003
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nuclear-retained non-coding RNA, NEAT1, which is not
detectable in hESCs. These findings, together with our data
suggest that non-coding RNA editing has different roles in hESCs
versus their differentiated derivatives.
Using RNAi silencing we have shown that Alu-sequence editing
in hESCs is highly dependant on ADAR1 expression level. Yet,
the control of global editing within repetitive element sequences
during hESC differentiation is more complex. We show here that
ADAR1 expression level is not significantly changed and that
ADAR2 and ADAR3 expression increased significantly as result of
hESC differentiation while the editing levels of Alu sequences
decreased. The discrepancy may be explained in part by the
possible role of ADAR3, whose expression level increased
significantly mainly during neural differentiation, as a possible
inhibitor of ADAR1 activity [48]. Other unknown factors which
are involved in regulation of editing processes may also change
during hESCs differentiation in a manner which affects global
editing patterns.
We demonstrate here that silencing of ADAR1 leads to
decreased global editing levels of Alu sequences in hESCs and
results in significant induction of the expression of genes related to
development and differentiation. However, we showed that
expression levels of pluripotency master regulator genes, specifi-
cally Nanog and Oct4, were not changed under ADAR1
knockdown conditions and that the hESC morphology was
compatible with the undifferentiated state. Our conclusion is
therefore that ADAR1 is not essential for maintenance of the
undifferentiated state of hESCs, at least in the short term.
Recently, it was demonstrated that ADAR1 is essential for the
maintenance of hematopoiesis and suppression of interferon
signaling [49]. The authors note that ADAR1 is dispensable for
mouse ESC self-renewal and EB formation, in accordance with
our findings in the human model. In addition, some studies suggest
Figure 4. RNA editing levels of Alu sequences are highly dependant on ADAR1 in hESCs. H9.2 hESCs were grown under feeder-free
conditions and transfected with ADAR1 siRNA or with non-target negative control siRNA. 44 h and 72 h after tranfection, total RNA and protein were
derived for analysis. (A) The relative mRNAs expression levels of ADAR1 p110 and ADAR1 p150 from the siRNAs transfected hESCs. Relative expression
levels were measured by qRT-PCR. Normalization was done using GAPDH. (B) Western blot analysis of ADAR1 p110 and ADAR1 p150 proteins after
the siRNA transfections. Lane 1 and lane 2 refer to ADAR1-siRNA and non-target control siRNA transfected cultures after 44 h, respectively. Lane 3 and
lane 4 refer to ADAR1-siRNA and control siRNA transfected cultures after 72 h, respectively. (C) The editing levels of BLCAP (Y/C) site and Alu
sequences of six other genes in ADAR1 knockdown versus control hESCs. RNA editing levels of C4orf29 and F11R Alu sequences were measured by
direct sequencing. C4orf29-Alu editing levels represent the average of 10 sites and F11R-Alu editing levels represent the average of 11 sites. Editing
levels of the BRCA1, FANCC, RBBP9 and MDM4 tanscripts were measured by primer extension followed by mass spectrometry using the Sequenom
MassArray in specific discrete sites. (D, E) A detailed representation of editing levels in the Alu sequences of C4orf29 and F11R in ADAR1 knockdown
versus control hESCs which were measured by direct sequencing. Specific localization of each editing site is given in Table S7.
doi:10.1371/journal.pone.0011173.g004
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to interfere with the ESC undifferentiated state, possibly because
ESC undifferentiated status depends mainly on the their master
regulator genes. For example, these studies showed that when
expression levels of many genes, related to diverse differentiation
processes, were increased by interfering with the Polycomb group
proteins, the undifferentiated state of the ESCs continued to be
maintained and the expression levels of the master regulators
remained high [50,51,52]. Similarly, editing may not be essential
for maintenance of hESC undifferentiated state. However, since
ADAR1 silencing results in an increase in the expression levels of
genes which are related to differentiation/developmental process-
es, we speculate that it may have a role in the regulation of early
cell differentiation processes.
Bioinformatics analysis suggests that neighboring, reversely
oriented Alu elements within 39UTRs, are often cleaved at both
ends of the region harboring the inverted repeats followed by
rejoining of the two parts of the transcript. These shortening events
are more common in tissues characterized by high editing levels [53].
Therefore, editing may induce shortening of 39UTRs. Recently, the
39UTRs of induced pluripotent stem (iPS) cells, which have many of
the characteristics of ESCs, were shown to be shorter than those of
their somatic cell of origin. The mechanism suggested for the
shortening is alternative polyadenylation [54], similar to the
mechanism implicated in 39UTR shortening in activated T cells
and cancer cells [55,56]. Similarly Prasanth et al implicated
alternative polyadenylation in the shortening of the mouse Slc7a2
39 UTR, resulting in removal of the hyperedited sequences involved
in anchoring to the nuclear parascpeckles [57]. We would like to
suggest an additional mechanism whereby the high level of editing in
undifferentiated embryonic stem cells may be related to the cleavage
and shortening of 39UTR sequences in such cells.
We can not rule out the possibility that other editing
independent functions of ADAR1 [58,59,60] mediated the
Figure 5. A global affect of ADAR1 silencing on gene expression in hESCs. 44 h after transfections, RNA were derived from hESCs treated
with ADAR1-siRNA or with non-target siRNA negative control and analyzed by oligonucleotide Microarray. Annotated genes whose expression level
was changed at least at 1.5 fold as a result of ADAR1 silencing were categorized into functional groups. Prominent functional groups of genes
which were overrepresented in the upregulated and/or downregulated genes are shown. One star indicates p-value,0.05. Two stars indicate
p-value,0.001.
doi:10.1371/journal.pone.0011173.g005
Table 1. Global effect of ADAR1 silencing on gene expression in hESCs.
Upregulated genes Downregulated genes
Type of functional group Number of genes P-value of overrepresentation Number of genes P-value of overrepresentation
Cell differentiation (general) 80 0.0000077 54 0.84
Neurogenesis 22 0.000094 8 0.88
Nucleic acid metabolic processes 103 0.76 173 0.000026
Protein metabolic processes 64 1.0 152 0.00067
Cancer 100 ,0.05 122 ,0.05
44 h after transfections, RNA were derived from hESCs treated with ADAR1-siRNA or with non-target siRNA negative control and analyzed by oligonucleotide
Microarray. Annotated genes whose expression level was changed at least at 1.5 fold as a result of ADAR1 silencing were categorized into functional groups. Prominent
functional groups of genes which were overrepresented in the upregulated and/or downregulated genes are shown.
doi:10.1371/journal.pone.0011173.t001
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related genes. However, our finding that Alu editing levels
decrease significantly during hESC differentiation, without a
decrease in ADAR1 expression levels, suggests that those
alterations are indeed editing dependent.
We and others showed that A-to-I RNA editing levels in various
solid tumors are significantly lower in comparison with the
corresponding normal tissues and that overexpression of ADARs
in brain tumor cell lines resulted in decreased proliferation and
migration rates [26,27]. These findings suggest that decreased
editing levels may contribute to tumorigenesis and cancer
pathogenesis. Cancer stem cells share a lot of features with normal
stem cells [61,62].Our findings here describing the significant
alteration of expression of cancer related genes by ADAR1
knockdown in hESCs further support the role of dysregulated
editing in cancer (Table S3).
In conclusion, our findings show that ADAR1 has a global
influence on the expression level of many genes that are related to
development processes, cancer, nucleic acid and protein process-
ing etc. This effect is probably mediated by the high editing levels
of Alu elements that appear in undifferentiated hESCs. Our data
strongly suggest that upon differentiation, Alu editing levels
decrease in a manner that may play a role in the regulation of
hESC early differentiation decisions.
Materials and Methods
Cell culture
hESCs (H9.2 and I6 [63,64]) were cultured on a mitomycyin C-
treated mouse embryonic fibroblasts (MEFs) feeder layer obtained
in medium consisting of 80% KnockOut DMEM, 20% KnockOut
serum replacement, 1 mM L-Glutamine, 0.1 mM b-mercapto-
ethanol, 1% non essential amino acids stock solution (6100),
4 ng/ml basic fibroblast growth factor (All from Gibco) and
Penicillin (50 units/ml)/Streptomycin (50 mg/ml) (Biological In-
dustries, Israel). To obtain feeder-free culture, hESCs were grown
on growth factor reduced Matrigel (BD Biosciences) coated plates
with MEFs conditioned medium [65]. In-vitro differentiation into
Embryoid Bodies (EBs) was performed by transferring hESCs
colonies to low attached Petri dishes (Miniplats, Ein-Shemer,
Israel) and growing them in medium consisting of 80% KnockOut
DMEM, 20% defined Fetal Bovine Serum (HyClone), 1 mM of L-
Glutamine, 1% of non essential amino acids stock solution (6100)
and Penicillin (50 units/ml)/Streptomycin (50 mg/ml). To differ-
entiate hESCs into neuronal cells, EBs were treated according to
Shuldiner et al [66] with few changes. In brief, after 4 days in
suspension, 5 mM all-trans retinoic acid (Sigma-Aldrich) were
added to the EBs medium. The medium was replaced every 2
days. After 21 days in suspension, cells were seeded on rat tail
collagen (Roche) in the same medium for an additional 2–3 days.
RNA purification and reverse transcription
Total RNA was isolated using Trizol reagent (Invitrogen)
according to the manufacturer’s instructions. Random-primed
cDNA synthesis was done on 1 mg- 2mg of total RNA using M-
MLV reverse transcriptase (Promega) according to manufacturer’s
instructions.
Quantitative Real-Time PCR (qRT-PCR)
qRT-PCRs were performed on a 7900HT ABI platform using
2X SYBR Green master mix (ABI). The relative mRNAs
expression levels analyses were done by the 2
2DDCT method with
GAPDH as the internal control for normalization. Data analysis
was performed using the SDS 2.1 Software (ABI). Primers are
listed in table S4.
Western blot
For protein derivation, cells pellets were lysed on ice by RIPA
lysis buffer consisting of 150 mM NaCl, 1% NP40, 0.5% sodium
deoxycholate, 0.1% SDS and 50 mM Tris-HCl PH 8 supple-
mented with protease inhibitor (Roche). Alternatively, proteins
were isolated from Trizol homogenates according to the
manufacturer’s instructions. Proteins were denaturated in sample
buffer, resolved on SDS-PAGE gel and transferred to nitrocellu-
lose membranes according to standard protocols. Following
blocking with 5% dry milk in Tris-buffered saline containing
0.05% Tween 20, the membranes were stained with the following
antibodies: Polyclonal anti ADAR1 (Generous gift from Brenda
Bass), polyclonal anti ADAR2 (Generous gift from Marie O ¨ hman)
or polyclonal anti Beta-Actin (Santa Cruz). Specific reactive bands
were detected using goat anti-rabbit (ADAR1 and ADAR2) or
donkey anti goat (Beta-Actin) conjugated to horseradish peroxi-
dase (Jackson Laboratory). Immunoreactive bands were visualized
by the SuperSignal West Pico Substrate Chemiluminescent kit
(Pierce).
Immunofluorescence staining
Cells were fixed with 4% paraformaldehyde for 25 minutes.
Oct4 staining: Cells were permeabilized and blocked in room
temperature in 2 stages: Cells were incubated for 10 minutes with
PBS containing 1% Triton X-100 (Sigma); Cells were then
incubated for a further 15 minutes with PBS supplemented with
1% Triton X-100 and 2% normal goat serum (Invitrogen).
Cells were incubated for 2 hours with mouse monoclonal Oct4
antibody (Chemicon) at a dilution of 1:20 in PBS supplemented
with 1% Triton X-100 and 2% normal goat serum.
Tubulin, beta 3 staining: Cells were permeabilized and blocked
for 30 minutes in a solution of PBS supplemented with 3% bovine
serum albumin (Sigma-Aldrich), 0.3% Triton X-100, and 5%
normal goat serum. The cells were incubated for 2 hours with
mouse monoclonal anti tubulin, beta 3 antibody (Sigma-Aldrich)
at a dilution of 1:1000 in the same solution.
Both stains were visualized by goat anti mouse Alexa Fluor 488
(Invitrogen, Molecular Probes) at a concentration of 1:1000.
Nuclear staining was performed by DAPI (Sigma).
Editing analysis by direct sequencing
PCR amplifications of known edited regions were done using
PCR Master Mix (Thermo Scientific). The resulting PCR-
fragments were purified using HiYield gel purification kit (RBC),
and sequenced using ABI Prism 3100 genetic analyzer (ABI). The
levels of editing assessed by sequencing were quantified by the DS
Gene program (Accelrys). Primers are listed in table S5.
Editing quantification by the SEQUENOME MassArray
technology
RNA editing detection was carried out using MALDI-TOF
mass spectrometer (Sequenom, San Diego, CA) as described for
mutation detection [67]. In brief, for each editing site two specific
primers flanking the editing site and one extension primer
complementary to a sequence adjacent to the editing site were
designed using MassARRAY assay design software (Sequenom).
Following amplification of the region of interest, a primer
extension reaction was carried out. This reaction included
sequence specific hybridization and sequence dependent termina-
tion that generated different products for the non-edited and
A-to-I RNA Editing in hESCs
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editing levels at specific sites were determined by spotting the
extension products onto silicon chips preloaded with proprietary
matrix (SpectroChip; Sequenom) that were subsequently read
by the MALDI-TOF mass spectrometer. Primers are listed in
table S6.
RNA interference
hESCs were plated at 2610
5 cells per well in a six-well plate and
were grown under feeder-free conditions. 24 hours later cells
transected with ADAR1-siRNA (ID: 119581, Ambion) or with
non-target siRNA control (AM4611- Negative control - #1,
Ambion) using Lipofectamine 2000 (Invitrogen). Lipofectamine -
siRNA complexes were produced in Opti-MEM I medium
(Invitrogen) according to the manufacturer protocol. Transfections
were done with a medium consisting of 2 ml MEFs conditioned
media and 1 ml Opti-MEM I containing 10 ml Lipofectamine and
200 pmol siRNA per well.
Oligonucleotide Microarrays
All experiments were performed using Affymetrix HU GEN-
E1.0st oligonucleotide. Total RNA from each sample was used to
prepare biotinylated target DNA, according to manufacturer
recommendations. Briefly, 100–600 ng of Total RNA was used to
generate first-strand cDNA by using a T7-random hexamers
primer. After second-strand synthesis, in vitro transcription was
performed. The resulting cRNA was then used for a second cycle
of first-strand cDNA by using a T7-random hexamers primer with
UTP resulting in SS DNA used for fragmentation and terminal
labeling. The target cDNA generated from each sample was
processed as per manufacturer’s recommendation using an
Affymetrix GeneChip Instrument System. Briefly, spike controls
were added to 5.5 mg fragmented cDNA before overnight
hybridisation. Arrays were then washed and stained with
streptavidin-phycoerythrin, before being scanned on an Affymetrix
GeneChip scanner. The quality and amount of starting RNA was
confirmed using Bioanalyser (Agilent). After scanning, array
images were assessed by eye to confirm scanner alignment and
the absence of significant bubbles or scratches on the chip surface.
Genes were analyzed using unsupervised hierarchical cluster
analysis (Spotfire DecisionSite for Functional Genomics; Somer-
ville, MA) and were filtered according to fold change calculation.
DAVID and Ingenuity IPA software (http://david.abcc.ncifcrf.
gov/, http://www.ingenuity.com/) were used for gene functional
classification and overrepresentation calculations. All data is
MIAME compliant and the raw data has been deposited in the
Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.
gov/geo) as GSE 19719 (temporary number).
Supporting Information
Figure S1 Differentiation of hESCs. H9.2 hESCs were trans-
ferred to suspension growth conditions and grown in EB medium
in order to induce differentiation (Day 0). On day 5, all-trans
retinoic acid was added to the medium in order to support mainly
neural differentiation. The cells in suspension were grown with
retinoic acid during 17 days. As control for the retinoic acid
supportive influence on neuronal enrichment and for the
induction of spontaneous differentiation, a second group of cells
were grown without retinoic acid (EBs). In order to estimate the
neuron frequency, the aggregates were dissociated by trypsiniza-
tion and seeded on rat tail collagen where they were grown for an
additional 2–3 days. (A) A typical hESCs colony growing in co-
culture with inactivated MEFs. Scale bar: 10 mm. (B, C)
Immunofluorescence staining of the hESCs specific protein,
Oct4 (green), before the differentiation treatment. DAPI staining
(Blue). Scale bar: 100 mm. (D,E). On day 22, the aggregates of the
retinoic acid treated group (D) were significantly less cystic than
the EBs (E). Scale bar: 1000 mm. (F,G) 3 days after seeding the
cells on collagen, most of the retinoic acid treated cells had a
typical neuronal morphology and were organized in a net like
structures (F). In contrast, in the culture of the seeded EBs, only a
minority of the cells had a neuronal morphology (G). Scale bar:
100 mm. (H,I) Immunostaining images demonstrating the expres-
sion of beta, 3 tubulin (TUBB3), a neuronal specific marker, in a
large fraction of the retinoic acid treated cells (H). In contrast, a
much smaller cells fraction expressed the TUBB3 protein in the
EBs culture (I). Scale bar: 240 mm. Green refers to TUBB3 and
blue refers to DAPI staining. (J,K) mRNA relative expression levels
of undifferentiated hESCs markers and neuronal markers were
measured in undifferentiated hESCs, retinoic acid treated cells and
seeded EBs by qRT-PCR. This data shows a significant decrease
at the expression level of the pluripotency markers, Oct4 and
Nanog, after the differentiation treatments (J). In addition there is
a significant increase at the expression level of the neuronal
markers, NF68, TUBB3, MAP2, ELAVL3 and NFH after retinoic
acid treatment (K). Measurments were normalized to GAPDH.
Found at: doi:10.1371/journal.pone.0011173.s001 (0.77 MB TIF)
Figure S2 Editing levels of Alu sequences during EBs differen-
tiation. H9.2 hESCs were differentiated spontaneously by EBs
derivation. Total RNA were derived from the undifferentiated
hESCs and the EBs after 1 week, 2 weeks and 3 weeks of growth in
suspension. Editing levels of F11R-Alu (A) and C4orf29-Alu (B) sites
are presented. Specific sites localization is presented in table S7.
Found at: doi:10.1371/journal.pone.0011173.s002 (0.69 MB TIF)
Figure S3 The expression level of ADAR1 RNA in hESCs. The
expression level of ADAR1 RNA in hESCs is significantly higher
than those of ADAR2 and ADAR3. (A) Microarray signal intensity
of ADAR1, ADAR2 and ADAR3 RNAs in undifferentiated H9.2
hESCs. (B) Real time PCR amplification plots of ADARs mRNA
in H9.2 undifferentiated hESCs.
Found at: doi:10.1371/journal.pone.0011173.s003 (2.18 MB TIF)
Figure S4 mRNA expression level of ADAR1 and ADAR2
during spontaneous differentiation of I6 hESCs. I6 hESCs were
differentiated to EBs. The relative expression levels of ADAR1
(Common region of both p110 and p150 isoforms) and ADAR2
mRNAs were measured by qRT-PCR at different times during the
differentiation, and in adult human cortex.
Found at: doi:10.1371/journal.pone.0011173.s004 (0.60 MB TIF)
Figure S5 ADAR1 knockdown in hESCs resulted in similar
expression levels of pluripotency markers and cell morphology. (A)
qRT-PCR analysis of Oct4 and Nanog. Relative mRNA levels
revealed similar levels in transient ADAR1 knockdown and
control hESCs. (B) Light microscopy images of transient ADAR1
knockdown and control hESCs, 72 h after siRNAs transfections,
revealed similar cell and colony morphology.
Found at: doi:10.1371/journal.pone.0011173.s005 (4.22 MB TIF)
Table S1 Downregulated genes after ADAR1 knockdown. 44 h
after transfections, RNA were derived from H9.2 hESCs that were
treated with ADAR1-siRNA or with non-target siRNA negative
control and analyzed by DNA Microarray. Annotated genes
whose expression level was changed at least 1.5 fold as a result of
ADAR1 silencing were categorized into functional groups by
DAVID Gene functional Classification Tool.
Found at: doi:10.1371/journal.pone.0011173.s006 (0.05 MB
XLS)
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after transfections, RNA were derived from H9.2 hESCs that were
treated with ADAR1-siRNA or with non-target siRNA negative
control and analyzed by DNA Microarray. Annotated genes
whose expression level was changed at least 1.5 fold as a result of
ADAR1 silencing were categorized into functional groups by
DAVID Gene functional Classification Tool.
Found at: doi:10.1371/journal.pone.0011173.s007 (0.07 MB
XLS)
Table S3 Cancer related genes that were regulated after
ADAR1 knockdown. This table represents cancer related genes
whose expression level was changed at least 1.5 fold as a result of
ADAR1 silencing. Analysis was performed using Ingenuity IPA
software.
Found at: doi:10.1371/journal.pone.0011173.s008 (0.02 MB
XLS)
Table S4 List of primers used for qRT-PCR.
Found at: doi:10.1371/journal.pone.0011173.s009 (0.03 MB
DOC)
Table S5 List of primers used for direct sequencing. Forward
and reverse primers were used for the amplification of the edited
region. The reverse primers were used as the sequencing primers.
Found at: doi:10.1371/journal.pone.0011173.s010 (0.03 MB
DOC)
Table S6 List of primers used for SEQUENOME MassArray
analysis.
Found at: doi:10.1371/journal.pone.0011173.s011 (0.04 MB
DOC)
Table S7 Localization of editing sites within Alu sequences (Mar.
2006 assembly (UCSC)).
Found at: doi:10.1371/journal.pone.0011173.s012 (0.02 MB
XLS)
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